Vertebral hemangiosarcoma as a cause of spinal cord compression in a dog
PDF
XML

Keywords

spinal cord compression, immunohistochemistry, primary neoplasm.

How to Cite

de Moura, F. B. C., Ximenes, P. P., Lazzaretti, S. S., de Siqueira, E. G. M., Kastelic, J., Alves, C. E. F., & Cagnini, D. Q. (2026). Vertebral hemangiosarcoma as a cause of spinal cord compression in a dog. Brazilian Journal of Veterinary Medicine, 48, e009425. https://doi.org/10.29374/2527-2179.bjvm009425

Abstract

Primary central nervous system (CNS) neoplasia is relatively rare in most domestic animal species, except dogs and cats, being directly associated with aging. On the other hand, hemangiosarcoma, lymphoma, mammary carcinoma and melanoma are the most common secondary tumors affecting CNS. They usually represent metastasis, and less frequently arising from nearby areas that infiltrate or compress CNS normal tissue, resulting in neurological clinical signs. This case report documents a 10-year-old female spayed Pinscher presenting with severe thoracolumbar pain and paraplegia due to a primary vertebral hemangiosarcoma (HSA). CT revealed a lytic lesion in the L1 vertebra causing dorsal displacement and spinal cord compression. Surgical removal of the neoplasm involved a bloc vertebral resection and stabilization with screws, cement, and soft tissue reconstruction, leading to marked clinical improvement. Histopathology confirmed an infiltrative primary bone HSA with positive immunohistochemical staining for endothelial marker. Postoperative adjuvant therapy with metronomic cyclophosphamide and propranolol was associated with extended survival and maintained quality of life over 13 months. This report underscores the importance of combined surgical and chemotherapeutic management for primary vertebral HSA in dogs, and this neoplasm as a less likely differential diagnosis for local invasive compressive neoplasms in CNS in dogs.

https://doi.org/10.29374/2527-2179.bjvm009425
PDF
XML

References

De Nardi, A. B., de Oliveira Massoco Salles Gomes, C., Fonseca-Alves, C. E., de Paiva, F. N., Linhares, L. C. M., Carra, G. J. U., dos Santos Horta, R., Ruiz Sueiro, F. A., Jark, P. C., Nishiya, A. T., de Carvalho Vasconcellos, C. H., Ubukata, R., Batschinski, K., Sobral, R. A., Fernandes, S. C., Biondi, L. R., De Francisco Strefezzi, R., Matera, J. M., Rangel, M. M. M., Anjos, D. S., Brunner, C. H. M., Laufer-Amorim, R., Cadrobbi, K. G., Cirillo, J. V., Martins, M. C., de Paula Reis Filho, N., Silva Lessa, D. F., Portela, R., Scarpa Carneiro, C., Ricci Lucas, S. R., Fukumasu, H., Feliciano, M. A. R., Gomes Quitzan, J., & Dagli, M. L. Z. (2023). Diagnosis, prognosis, and treatment of canine hemangiosarcoma: A review based on a consensus organized by the Brazilian Association of Veterinary Oncology, ABROVET. Cancers, 15(7), 2025. https://doi.org/10.3390/cancers15072025. PMid:37046686.

Elmslie, R. E., Glawe, P., & Dow, S. W. (2008). Metronomic therapy with cyclophosphamide and piroxicam effectively delays tumor recurrence in dogs with incompletely resected soft tissue sarcomas. Journal of Veterinary Internal Medicine, 22(6), 1373-1379. https://doi.org/10.1111/j.1939-1676.2008.0179.x. PMid:18976288.

Hammer, A. S., Couto, C. G., Filppi, J., Getzy, D., & Shank, K. (1991). Efficacy and toxicity of VAC chemotherapy (Vincristine, Doxorubicin, and Cyclophosphamide) in dogs with hemangiosarcoma. Journal of Veterinary Internal Medicine, 5(3), 160-166. https://doi.org/10.1111/j.1939-1676.1991.tb00943.x. PMid:1920253.

Lana, S., U’ren, L., Plaza, S., Elmslie, R., Gustafson, D., Morley, P., & Dow, S. (2007). Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs. Journal of Veterinary Internal Medicine, 21(4), 764-769. https://doi.org/10.1892/0891-6640(2007)21[764:CLOCFA]2.0.CO;2. PMid:17708397.

Mulia, G. E., Picanço-Castro, V., Stavrou, E. F., Athanassiadou, A., & Figueiredo, M. L. (2021). Advances in the development and the applications of nonviral, episomal vectors for gene therapy. Human Gene Therapy, 32(19-20), 1076-1095. https://doi.org/10.1089/hum.2020.310. PMid:34348480.

Nelson, B. L., & Thompson, L. D. R. (2007). Sinonasal tract angiosarcoma: A clinicopathologic and immunophenotypic study of 10 cases with a review of the literature. Head and Neck Pathology, 1(1), 1-12. https://doi.org/10.1007/ s12105-007-0017-2. PMid:20614274.

Parchman, M. B., & Crameri, F. M. (1989). Primary vertebral hemangiosarcoma in a dog. Journal of the American Veterinary Medical Association, 194(1), 79-81. https://doi.org/10.2460/javma.1989.194.01.79. PMid:2914798.

Pérez-Martínez, C., Regueiro-Purriños, M., Fernández-Martínez, B., Altónaga, J. R., Gonzalo-Orden, J. M., & García-Iglesias, M. J. (2016). Magnetic resonance imaging and immunohistochemistry of primary vertebral hemangiosarcoma in a dog and implications for diagnosis and therapy. The Canadian Veterinary Journal = La Revue Vétérinaire Canadienne, 57(12), 1247-1250. PMid:27928170.

Ray-Coquard, I. L., Domont, J., Tresch-Bruneel, E., Bompas, E., Cassier, P. A., Mir, O., Piperno-Neumann, S., Italiano, A., Chevreau, C., Cupissol, D., Bertucci, F., Bay, J.-O., Collard, O., Saada-Bouzid, E., Isambert, N., Delcambre, C., Clisant, S., Le Cesne, A., Blay, J.-Y., & Penel, N. (2015). Paclitaxel given once per week with or without bevacizumab in patients with advanced angiosarcoma: A randomized phase II trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 33(25), 2797-2802. https://doi.org/10.1200/JCO.2015.60.8505. PMid:26215950.

Reis, M. DE O., Slaviero, M., Lorenzett, M. P., Cruz, R. A. S., Guimarães, L. L. B., Pavarini, S. P., Driemeier, D., & Sonne, L. (2017). Neoplasmas bovinos diagnosticados no Setor de Patologia Veterinária da UFRGS, Porto Alegre (2005-2014). Pesquisa Veterinária Brasileira, 37(2), 105-109. https://doi.org/10.1590/s0100-736x2017000200002.

Stock, M. L., Smith, B. I., & Engiles, J. B. (2011). Disseminated hemangiosarcoma in a cow. The Canadian Veterinary Journal = La Revue Vétérinaire Canadienne, 52(4), 409-413. PMid:21731096.

Terauchi, M., Fujii, Y., Goto, S., Iwasaki, R., Yoshikawa, R., & Mori, T. (2023). Efficacy and adverse events of anthracycline and propranolol combination in five dogs with stage 3 hemangiosarcoma. Open Veterinary Journal, 13(6), 801-806. https://doi.org/10.5455/OVJ.2023.v13.i6.15. PMid:37545711.

Wang, G., Wu, M., Durham, A. C., Radaelli, E., Mason, N. J., Xu, X., & Roth, D. B. (2020). Molecular subtypes in canine hemangiosarcoma reveal similarities with human angiosarcoma. PLoS One, 15(3), e0229728. https://doi.org/10.1371/journal.pone.0229728. PMid:32210430.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2026 Fernanda Barthelson Carvalho de Moura, Pedro Pol Ximenes, Silmara Santos Lazzaretti, Emerson Gonçalves Martins de Siqueira, John Kastelic, Carlos Eduardo Fonseca Alves, Didier Quevedo Cagnini